Eli Lilly and Company
MX ˙ BMV ˙ US5324571083
SecurityMX:LLY / Eli Lilly and Company
InstitutionNavellier & Associates Inc
Latest Disclosed Ownership27,494 shares
Latest Disclosed Value $ 25,287,988
Navellier & Associates Inc reports 5.80% increase in ownership of LLY / Eli Lilly and Company

On May 7, 2026 - Navellier & Associates Inc filed a 13F-HR form disclosing ownership of 27,494 shares of Eli Lilly and Company (MX:LLY) valued at $25,287,988 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 25,987 shares of Eli Lilly and Company. This represents a change in shares of 5.80% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F Eli Lilly and COM 532457108 27,494 1,507 5.80 25,288 -9.45 2.6355
2026-02-03 2025-12-31 13F Eli Lilly and com 532457108 25,987 -33 -0.13 27,927 40.68 3.1295
2025-11-06 2025-09-30 13F Eli Lilly and COM 532457108 26,020 1,879 7.78 19,853 5.49 2.0137
2025-08-07 2025-06-30 13F Eli Lilly and COM 532457108 24,141 -415 -1.69 18,819 -6.71 2.3309
2025-05-06 2025-03-31 13F Eli Lilly and COM 532457108 24,556 -1,442 -5.55 20,172 0.50 2.7861
2025-02-03 2024-12-31 13F Eli Lilly and COM 532457108 25,998 1,027 4.11 20,070 -9.28 2.4065
2024-11-12 2024-09-30 13F Eli Lilly and COM 532457108 24,971 -1,728 -6.47 22,123 -8.48 2.9990
2024-08-08 2024-06-30 13F Eli Lilly and COM 532457108 26,699 1,094 4.27 24,173 21.35 2.8382
2024-05-14 2024-03-31 13F Eli Lilly and COM 532457108 25,605 1,499 6.22 19,920 41.76 2.4545
2024-02-08 2023-12-31 13F Eli Lilly and COM 532457108 24,106 2,254 10.31 14,052 19.72 2.1053
2023-11-09 2023-09-30 13F Eli Lilly and COM 532457108 21,852 9,125 71.70 11,737 96.67 2.0101
2023-08-07 2023-06-30 13F Eli Lilly and COM 532457108 12,727 -304 -2.33 5,969 33.36 1.1624
2023-05-12 2023-03-31 13F Eli Lilly COM 532457108 13,031 -3,718 -22.20 4,475 -26.96 0.9415
2023-02-02 2022-12-31 13F Eli Lilly COM 532457108 16,749 -858 -4.87 6,127 7.62 1.2485
2022-11-09 2022-09-30 13F Eli Lilly COM 532457108 17,607 -367 -2.04 5,693 -2.32 1.2658
2022-08-12 2022-06-30 13F Eli Lilly COM 532457108 17,974 17,974 5,828 1.2510
2021-08-09 2021-06-30 13F Eli Lilly COM 532457108 0 -2,000 -100.00 0 -100.00
2021-05-12 2021-03-31 13F Eli Lilly COM 532457108 2,000 -100 -4.76 374 5.35 0.0673
2021-02-05 2020-12-31 13F Eli Lilly COM 532457108 2,100 0 0.00 355 14.15 0.0643
2020-11-09 2020-09-30 13F Eli Lilly COM 532457108 2,100 0 0.00 311 -9.86 0.0678
2020-08-12 2020-06-30 13F Eli Lilly COM 532457108 2,100 -100 -4.55 345 13.11 0.0820
2020-05-13 2020-03-31 13F Eli Lilly COM 532457108 2,200 200 10.00 305 15.97 0.0717
2020-02-12 2019-12-31 13F Eli Lilly COM 532457108 2,000 200 11.11 263 30.85 0.0424
2019-10-16 2019-09-30 13F Eli Lilly COM 532457108 1,800 -100 -5.26 201 -4.74 0.0333
2019-07-17 2019-06-30 13F Eli Lilly COM 532457108 1,900 100 5.56 211 -9.83 0.0326
2019-05-15 2019-03-31 13F Eli Lilly COM 532457108 1,800 -100 -5.26 234 6.36 0.0363
2019-01-15 2018-12-31 13F Eli Lilly COM 532457108 1,900 -230 -10.80 220 -3.93 0.0374
2018-11-14 2018-09-30 13F Eli Lilly COM 532457108 2,130 -270 -11.25 229 11.71 0.0296
2018-08-06 2018-06-30 13F Eli Lilly COM 532457108 2,400 2,400 205 0.0285
2018-05-21 2018-03-31 13F Eli Lilly COM 532457108 0 -3,512 -100.00 0 -100.00
2018-02-12 2017-12-31 13F Eli Lilly COM 532457108 3,512 -6,700 -65.61 297 -66.02 0.0555
2017-11-14 2017-09-30 13F Eli Lilly COM 532457108 10,212 -5,388 -34.54 874 -31.93 0.1698
2017-08-24 2017-06-30 13F Eli Lilly COM 532457108 15,600 -700 -4.29 1,284 -6.35 0.1918
2017-04-21 2017-03-31 13F Eli Lilly COM 532457108 16,300 -500 -2.98 1,371 10.92 0.1998
2017-02-13 2016-12-31 13F Eli Lilly COM 532457108 16,800 -800 -4.55 1,236 -12.53 0.2043
2016-10-24 2016-09-30 13F Eli Lilly COM 532457108 17,600 -737 -4.02 1,413 -2.15 0.2020
2016-08-03 2016-06-30 13F Eli Lilly COM 532457108 18,337 535 3.01 1,444 12.64 0.2156
2016-05-13 2016-03-31 13F Eli Lilly COM 532457108 17,802 391 2.25 1,282 -12.61 0.1664
2016-02-10 2015-12-31 13F Eli Lilly COM 532457108 17,411 3,091 21.59 1,467 22.45 0.1614
2015-10-20 2015-09-30 13F Eli Lilly COM 532457108 14,320 10,748 300.90 1,198 302.01 0.1206
2015-07-08 2015-06-30 13F Eli Lilly COM 532457108 3,572 3,572 298 0.0261
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.